Washington Drug Letter

For more than 40 years, WDL’s team of journalists has been the eyes and ears of pharmaceutical executives in Washington when it comes to the US Congress and agencies like FDA, NIH, CMS, DOJ, FTC, and the HHS Office of the Inspector General. WDL covers enforcement activities, rulemaking, guidance development, court cases and precedents, congressional actions and new laws affecting the industry. In every issue, you get links to important documents, such as FDA letters, guidances, rules, full texts of proposed legislation, GAO reports and more. NEW 2013 FEATURES: You will now get weekly information on new warning letters, what is buzzing at the FDA, the FDA calendar, the most recent FOIA requests and current court and legislative actions.